Login / Signup

Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks.

Natalia RompotiMaria PolitouIrene StefanakiCharitomeni VavouliMarina PapoutsakiAfroditi NeofotistouDimitrios RigopoulosAlexander StratigosElectra Nicolaidou
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Our study confirms the high effectiveness and good safety profile of brodalumab in the real-world setting.
Keyphrases
  • randomized controlled trial
  • systematic review
  • coronary artery disease
  • electronic health record
  • emergency department
  • big data
  • machine learning
  • free survival
  • adverse drug
  • data analysis